COVID-19's Impact on the Cold & Flu Drugs Industry, Forecast to 2027

DUBLIN, June 16, 2020 /PRNewswire/ -- The "Cold & Flu Drugs - Global Market Outlook (2018-2027)" report has been added to's offering.

The Global Cold & Flu Drugs market accounted for $12.78 billion in 2018 and is expected to reach $26.4 billion by 2027, growing at a CAGR of 8.4% during the forecast period.

Some of the key factors propelling the market growth include increasing cases of obesity all over the globe, increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress. However, cold & flu drugs may causes allergic reaction is likely to hamper the market.

By application, over the counter (OTC) drugs segment is poised to witness lucrative growth over the forecast timeframe, due to increasing prevalence of digestion disorders, common flu, and cold. Over-the-counter (OTC) drugs also called as non-prescription drugs are medicines that do not require prescription from healthcare professionals for selling it to consumers. These drugs are available at pharmacies, supermarkets, general stores, and gas stations across several countries. However, these drugs are solely authorized for dispense by pharmacists, after confirming age, identity, and patient's knowledge regarding the product and its utility.

On the basis of geography, Asia Pacific region is projected to have considerable market growh during the forecast period, owing to growing patient awareness regarding consumption of OTC drugs, leading to self-medication practices. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.

Some of the key players in cold & flu drugs market include Bayer, AstraZeneca, Procter and Gamble, Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Sun Pharmaceutical Industries, Pfizer, and Prestige Brands Holdings.

What the report offers:

    --  Market share assessments for the regional and country-level segments
    --  Strategic recommendations for the new entrants
    --  Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    --  Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges,
        Investment Opportunities, and recommendations)
    --  Strategic analysis: Drivers and Constraints, Product/Technology
        Analysis, Porter's five forces analysis, SWOT analysis, etc.
    --  Strategic recommendations in key business segments based on the market
    --  Competitive landscaping mapping the key common trends
    --  Company profiling with detailed strategies, financials, and recent
    --  Supply chain trends mapping the latest technological advancements

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of COVID-19

4 Porters Five Force Analysis

5 Global Cold & Flu Drugs Market, By Product Type
5.1 Introduction
5.2 Decongestants
5.3 Antibiotics
5.4 Antihistamines
5.5 Expectorants
5.6 Bronchodilators

6 Global Cold & Flu Drugs Market, By Application
6.1 Introduction
6.2 Rx Drugs
6.3 Over the Counter (OTC) Drugs

7 Global Cold & Flu Drugs Market, By Geography
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 South America
7.6 Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Bayer
9.2 AstraZeneca
9.3 Procter and Gamble
9.4 Reckitt Benckiser Group
9.5 Johnson & Johnson
9.6 GlaxoSmithKline
9.7 Novartis
9.8 Sun Pharmaceutical Industries
9.9 Pfizer
9.10 Prestige Brands Holdings

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets